These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11457856)

  • 1. Estrogen receptor (ER)-alpha, but not ER-beta, mediates regulation of the insulin-like growth factor I gene by antiestrogens.
    Fournier B; Gutzwiller S; Dittmar T; Matthias G; Steenbergh P; Matthias P
    J Biol Chem; 2001 Sep; 276(38):35444-9. PubMed ID: 11457856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17beta-estradiol potently suppresses cAMP-induced insulin-like growth factor-I gene activation in primary rat osteoblast cultures.
    McCarthy TL; Ji C; Shu H; Casinghino S; Crothers K; Rotwein P; Centrella M
    J Biol Chem; 1997 Jul; 272(29):18132-9. PubMed ID: 9218447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin-like growth factor-I in regulating estrogen receptor-alpha gene expression.
    Stoica A; Saceda M; Fakhro A; Joyner M; Martin MB
    J Cell Biochem; 2000 Jan; 76(4):605-14. PubMed ID: 10653980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
    Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells. Mechanisms for its atheroprotective effects.
    Scheidegger KJ; Cenni B; Picard D; Delafontaine P
    J Biol Chem; 2000 Dec; 275(49):38921-8. PubMed ID: 10982795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the folate receptor alpha gene by the estrogen receptor: mechanism and implications in tumor targeting.
    Kelley KM; Rowan BG; Ratnam M
    Cancer Res; 2003 Jun; 63(11):2820-8. PubMed ID: 12782587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.
    Umayahara Y; Kawamori R; Watada H; Imano E; Iwama N; Morishima T; Yamasaki Y; Kajimoto Y; Kamada T
    J Biol Chem; 1994 Jun; 269(23):16433-42. PubMed ID: 8206951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
    van den Wijngaard A; Mulder WR; Dijkema R; Boersma CJ; Mosselman S; van Zoelen EJ; Olijve W
    Mol Endocrinol; 2000 May; 14(5):623-33. PubMed ID: 10809227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
    Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
    J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
    Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
    J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
    Montano MM; Jaiswal AK; Katzenellenbogen BS
    J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen agonism and estrogen antagonism of c-fos gene promoter activity through non-consensus-responsive elements in MC3T3-E1 osteoblasts.
    Ishibashi O; Yamagishi T; Hanada K; Kawashima H
    Biochem Biophys Res Commun; 2001 Dec; 289(3):705-11. PubMed ID: 11726205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxyl or counterpart hydroxyl with histidine 524 of the human estrogen receptor alpha.
    Aliau S; Mattras H; Richard E; Bonnafous JC; Borgna JL
    Biochemistry; 2002 Jun; 41(25):7979-88. PubMed ID: 12069588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.